Treatment with the BCL-2/BCL-xL inhibitor senolytic drug ABT263/Navitoclax improves functional hyperemia in aged mice.
Tarantini S, Balasubramanian P, Delfavero J, Csipo T, Yabluchanskiy A, Kiss T, Nyúl-Tóth Á, Mukli P, Toth P, Ahire C, Ungvari A, Benyo Z, Csiszar A, Ungvari Z.
Tarantini S, et al. Among authors: csiszar a.
Geroscience. 2021 Oct;43(5):2427-2440. doi: 10.1007/s11357-021-00440-z. Epub 2021 Aug 24.
Geroscience. 2021.
PMID: 34427858
Free PMC article.